121.66
2.70%
+3.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$118.46
Aprire:
$119.49
Volume 24 ore:
1.76M
Capitalizzazione di mercato:
$25.03B
Reddito:
$7.39B
Utile/perdita netta:
$1.02B
Rapporto P/E:
50.48
EPS:
2.41
Flusso di cassa netto:
$1.20B
1 W Prestazione:
+1.94%
1M Prestazione:
-6.42%
6M Prestazione:
+11.87%
1 anno Prestazione:
-12.86%
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
574-267-6131
Indirizzo
345 East Main Street, Warsaw, IN
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
2023-10-20 | Iniziato | ROTH MKM | Neutral |
2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
2023-03-29 | Iniziato | UBS | Sell |
2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2022-10-18 | Iniziato | Barclays | Underweight |
2022-10-12 | Iniziato | Jefferies | Underperform |
2022-05-27 | Downgrade | Needham | Buy → Hold |
2022-04-13 | Downgrade | Truist | Buy → Hold |
2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
2022-03-02 | Ripresa | BofA Securities | Underperform |
2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
2022-02-08 | Reiterato | Citigroup | Buy |
2022-02-08 | Reiterato | Deutsche Bank | Hold |
2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
2022-02-08 | Reiterato | JP Morgan | Neutral |
2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
2022-02-08 | Reiterato | Stifel | Buy |
2022-02-08 | Reiterato | Truist | Buy |
2022-02-08 | Reiterato | UBS | Neutral |
2022-02-08 | Reiterato | Wells Fargo | Underweight |
2022-02-02 | Downgrade | UBS | Buy → Neutral |
2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
2021-12-07 | Iniziato | Loop Capital | Buy |
2021-11-23 | Downgrade | Argus | Buy → Hold |
2021-09-14 | Ripresa | Raymond James | Mkt Perform |
2021-05-25 | Iniziato | Barclays | Overweight |
2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
2020-12-18 | Reiterato | Needham | Strong Buy |
2020-10-20 | Iniziato | Northland Capital | Market Perform |
2020-09-11 | Iniziato | Wolfe Research | Outperform |
2020-08-05 | Reiterato | Needham | Strong Buy |
2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
2020-04-07 | Reiterato | Needham | Strong Buy |
2020-03-05 | Iniziato | Citigroup | Buy |
2020-02-13 | Iniziato | Goldman | Buy |
2020-01-08 | Iniziato | SunTrust | Buy |
2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2019-08-12 | Aggiornamento | Argus | Hold → Buy |
2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Analyst Expectations For Zimmer Biomet Holdings's Future
Benzinga
Zimmer Biomet (ZBH) Q1 Earnings Beat, Margins Expand
Zacks Investment Research
Zimmer Biomet (ZBH) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research
Will These 5 MedTech Stocks Beat Forecasts This Earnings Season?
Zacks Investment Research
Earnings Preview: biote Corp. (BTMD) Q1 Earnings Expected to Decline
Zacks Investment Research
Unlocking Q1 Potential of Zimmer (ZBH): Exploring Wall Street Estimates for Key Metrics
Zacks Investment Research
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Zimmer Biomet Holdings Inc (ZBH) Reddito 2024
ZBH ha riportato un ricavo (TTM) di $7.39 miliardi per il trimestre terminato il 2023-12-31, un +6.55% salita anno su anno.
Zimmer Biomet Holdings Inc (ZBH) Reddito netto 2024
ZBH l'utile netto (TTM) è stato di $1.02 miliardi per il trimestre terminato il 2023-12-31, un +342.52% aumento anno su anno.
Zimmer Biomet Holdings Inc (ZBH) Flusso di cassa 2024
ZBH ha registrato un flusso di cassa disponibile (TTM) di $1.20 miliardi per il trimestre conclusosi con 2023-12-31, un +9.78% aumento anno su anno.
Zimmer Biomet Holdings Inc (ZBH) Utile per azione 2024
L'utile per azione (TTM) di ZBH è stato pari a $4.89 per il trimestre terminato il 2023-12-31, un +344.55% crescita anno su anno.
Capitalizzazione:
|
Volume (24 ore):